Explore the pros and cons of oral versus injectable MAT in the carceral setting. The presenter will share the journey as much-needed therapy was provided to a vulnerable population. After treating 8,000 patients with buprenorphine/Suboxone and giving more than 12,000 doses of the injectable Sublocade and Brixadi, there are lessons to be discussed, along with program development and costs.

Educational Objectives

• Discuss the advantages and disadvantages of oral versus injectable MAT

•  Describe patient attitudes to oral versus injectable MAT

• Identify direct and indirect costs of different MAT options

Level: Intermediate